COPENHAGEN (Reuters) – Denmark’s Novo Nordisk, the world’s largest insulin maker, is betting on a new way to stay ahead in the $40 billion-plus diabetes market by trying to develop the world’s first once-weekly insulin injection. It is an ambitious and risky project,…
Source:Novo Nordisk’s next big idea: a once-weekly insulin shot
Wednesday, October 1, 2014
Novo Nordisk's next big idea: a once-weekly insulin shot
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment